Galam is the famous Corporate Investor, which was founded in 1940.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Ofer Hi-Tech, Millennium II Materials Technology Fund, Arancia International. In the next rounds fund is usually obtained by TPY Capital, Frutarom.
Among the most popular portfolio startups of the fund, we may highlight Enzymotec. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular fund investment industries, there are Manufacturing, Biotechnology.
The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2009.
| Fund Name | Location |
| Acario Innovation | California, Menlo Park, United States |
| Alkemi Venture Partners | Delhi, India, New Delhi |
| ASU Innovation Open | - |
| Beijing Envision Investment Management Co. | Beijing, Beijing, China |
| Changchun UP Optotech Co., Ltd. | Changchun, China, Jilin |
| Deguang Shengan | Beijing, China, Haidian |
| Eideard Venture Capital | - |
| Fashion 22 | - |
| Gaocheng Rongxin | China, Guangdong, Shenzhen |
| MCube8 | - |
| Moken | British Columbia, Canada, Vancouver |
| OneEleven | Canada, Ontario, Toronto |
| PDL Biopharma | Incline Village, Nevada, United States |
| Pobts | Netherlands, Noord-Holland, North Holland |
| Qianhai Jinheng Touzi | China, Guangdong, Shenzhen |
| Social Venture Partners | Seattle, United States, Washington |
| WE Ventures | Brazil, São Paulo, Sao Paulo |
| Zhiobo Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Enzymotec | $11M | 02 Feb 2009 | North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Enzymotec | $11M | 02 Feb 2009 | North District |
